Tekada will import 50 mln doses of Moderna’s coronavirus vaccine candidate in Japan
The FINANCIAL — Takeda Pharmaceutical Company Limited announced that it will import and distribute 50 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273, starting in the first half of 2021, pending licensure in Japan. This effort is part of a three-way agreement among Takeda, Moderna and the Government of Japan’s Ministry of Health Labour and Welfare (MHLW). Moderna has previously
Latest comments